Abstract
Abstract
Background
The Chinese government, announced new 10 measures for COVID-19 response on December 7, 2022, which meant the thorough abolishment of the dynamic zero-COVID-19 policy. The actual number of SARS-CoV-2-infected residents was much larger than the official data due to the cancellation of large-scale nucleic acid testing.
Methods
This work is a re-analysis of published COVID-19 data. The COVID-19 surveillance data were derived from Human-Society Communication, which is a public service agency for employment. The information of the main endemic strains of SARS-CoV-2 in the Chinese mainland during the Omicron wave obtained from the Chinese Center for Disease Control and Prevention. Human-Society Communication issued online questionnaires of COVID-19 to all Chinese residents via the WeChat Public Account during December 20–21, 2022. Thereafter, Human-Society Communication issued online questionnaires of COVID-19 for the second time on December 26, 2022.
Results
A total of 122,806 residents participated in the first online questionnaire survey during the two days. The results showed that 74,689 participants (60.8%) were infected with SARS-CoV-2 Omicron variants. For the second online questionnaire survey, a total of 47,897 residents participated in the survey in a day. The results showed that the infection rate of COVID-19 in the Chinese mainland was increased from 60.8–73.5% during December 21–26, 2022. The main endemic strains of SARS-CoV-2 were BA.5.2 and BF.7 according to the analysis results of SARS-CoV-2 genome sequences.
Conclusions
Both SARS-CoV-2 Omicron subvariants BA.5.2 and BF.7 had extremely strong transmissibility, and large-scale COVID-19 infections posed unprecedented challenges on the Chinese mainland.
Funder
Guangxi Zhuang Autonomous Region Health and Family Planning Commission
Publisher
Research Square Platform LLC
Reference13 articles.
1. 1. National Health Commission of the People's Republic of China. Notification of futher optimization and implementation of prevention and control measures against COVID-19. http://www.nhc.gov.cn/xcs/gzzcwj/202212/8278e7a7aee34e5bb378f0e0fc94e0f0.shtml. 2022 Accessed December 7 2022.
2. 2. National Health Commission of the People's Republic of China. Interpretation and reply of the notification of futher optimization and implementation of prevention and control measures against COVID-19. http://www.nhc.gov.cn/xcs/fkdt/202212/3b3c4f4c101e47ac8c2792c1de079561.shtml. 2022 Accessed December 7 2022.
3. 3. Sun D-X. A total of 3.451677 billion doses of COVID-19 vaccines had been vaccinated by the end of December 13, 2022; 2022.
4. 4. Fan Y, Li X, Zhang L, Wan S, Zhang L, Zhou F. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther. 2022;7:141.
5. 5. Shrestha LB, Foster C, Rawlinson W, Tedla N, Bull RA. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission. Rev Med Virol. 2022;32:e2381.